Revision history of "Durvalumab (Imfinzi)"

Jump to navigation Jump to search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

(newest | oldest) View ( | older 50) (20 | 50 | 100 | 250 | 500)
  • curprev 21:34, 23 March 2017‎ PeterYang talk contribs‎ 2,010 bytes +2,010‎ Created page with "'''in clinical trials''' ==General information== Class/mechanism: PD-L1 blocking antibody. PD-L1 (programmed death-1 ligand 1) expressed on tumor cells and tumor-infiltrating..."
(newest | oldest) View ( | older 50) (20 | 50 | 100 | 250 | 500)
Retrieved from "https://hemonc.org/wiki/Durvalumab_(Imfinzi)"